These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 25075840)
1. Treatment of malaria--a continuing challenge. Greenwood B N Engl J Med; 2014 Jul; 371(5):474-5. PubMed ID: 25075840 [No Abstract] [Full Text] [Related]
2. Spread of artemisinin resistance in malaria. Hawkes M; Conroy AL; Kain KC N Engl J Med; 2014 Nov; 371(20):1944-5. PubMed ID: 25390755 [No Abstract] [Full Text] [Related]
3. [The current status of the resistance of malaria pathogens to antimalarials]. Kondrashin AV; Baranova AM; Morozov EN; Morozova LF; Stepanova EV Med Parazitol (Mosk); 2014; (3):51-7. PubMed ID: 25286554 [TBL] [Abstract][Full Text] [Related]
4. Evidence of Artemisinin-Resistant Plasmodium falciparum Malaria in Eastern India. Das S; Saha B; Hati AK; Roy S N Engl J Med; 2018 Nov; 379(20):1962-1964. PubMed ID: 30428283 [No Abstract] [Full Text] [Related]
5. Spiroindolone KAE609 for falciparum and vivax malaria. White NJ; Pukrittayakamee S; Phyo AP; Rueangweerayut R; Nosten F; Jittamala P; Jeeyapant A; Jain JP; Lefèvre G; Li R; Magnusson B; Diagana TT; Leong FJ N Engl J Med; 2014 Jul; 371(5):403-10. PubMed ID: 25075833 [TBL] [Abstract][Full Text] [Related]
6. Coartem (artemether-lumefantrine) in Africa: the beginning of the end? Hastings IM; Ward SA J Infect Dis; 2005 Oct; 192(7):1303-4; author reply 1304-5. PubMed ID: 16136476 [No Abstract] [Full Text] [Related]
7. Proteomic approaches to studying drug targets and resistance in Plasmodium. Cooper RA; Carucci DJ Curr Drug Targets Infect Disord; 2004 Mar; 4(1):41-51. PubMed ID: 15032633 [TBL] [Abstract][Full Text] [Related]
11. Antimalarial drug combinations in vastly different settings. Morrow RH Lancet; 2007 Feb; 369(9560):444-5. PubMed ID: 17292746 [No Abstract] [Full Text] [Related]
12. Can a single "powerless" mitochondrion in the malaria parasite contribute to parasite programmed cell death in the asexual stages? Ch'ng JH; Yeo SP; Shyong-Wei Tan K Mitochondrion; 2013 May; 13(3):254-6. PubMed ID: 23123916 [TBL] [Abstract][Full Text] [Related]
13. [Towards a better understanding of the molecular mechanisms of P. falciparum resistance to artemisinin]. Khim N; Witkowski B; Duru V; Ariey F; Mercereau-Puijalon O; Ménard D Med Sci (Paris); 2014; 30(8-9):727-9. PubMed ID: 25174743 [No Abstract] [Full Text] [Related]
14. High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia. Schunk M; Kumma WP; Miranda IB; Osman ME; Roewer S; Alano A; Löscher T; Bienzle U; Mockenhaupt FP Malar J; 2006 Jul; 5():54. PubMed ID: 16817953 [TBL] [Abstract][Full Text] [Related]
15. Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda. Nsobya SL; Dokomajilar C; Joloba M; Dorsey G; Rosenthal PJ Antimicrob Agents Chemother; 2007 Aug; 51(8):3023-5. PubMed ID: 17562798 [TBL] [Abstract][Full Text] [Related]
16. Artemisinin resistance in Plasmodium falciparum malaria. Taylor SM; Juliano JJ; Meshnick SR N Engl J Med; 2009 Oct; 361(18):1807; author reply 1808. PubMed ID: 19864681 [No Abstract] [Full Text] [Related]
17. Skirmishing over the scope of the threat. Roberts L Science; 2016 Apr; 352(6284):403. PubMed ID: 27102460 [No Abstract] [Full Text] [Related]
18. Lack of prediction of mefloquine and mefloquine-artesunate treatment outcome by mutations in the Plasmodium falciparum multidrug resistance 1 (pfmdr1) gene for P. falciparum malaria in Peru. Pillai DR; Hijar G; Montoya Y; Marouiño W; Ruebush TK; Wongsrichanalai C; Kain KC Am J Trop Med Hyg; 2003 Jan; 68(1):107-10. PubMed ID: 12557835 [TBL] [Abstract][Full Text] [Related]